Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
La Jolla Pharmaceutical's peak revenue was $75.7M in 2021. The peak quarterly revenue was $34.1M in 2021(q1).
La Jolla Pharmaceutical's revenue increased from $8.1m in 2009 to $75.7M currently. That's a 831.94% change in annual revenue.
| Fiscal year / year | La Jolla Pharmaceutical revenue |
|---|---|
| 2009 | $8.1M |
| 2015 | $1.1M |
| 2016 | $616,000 |
| 2018 | $10.1M |
| 2019 | $23.1M |
| 2020 | $33.4M |
| 2021 | $75.7M |
How accurately did La Jolla Pharmaceutical's revenue projections match actual performance?
La Jolla Pharmaceutical saw the greatest revenue growth in 2018, when revenue increased by 1,539.29%.
La Jolla Pharmaceutical had the lowest revenue growth in 2015, when revenue changed by -86.99%.
| Year | La Jolla Pharmaceutical growth |
|---|---|
| 2015 | -87%↓ |
| 2016 | -42%↓ |
| 2018 | 1539%↑ |
| 2019 | 128%↑ |
| 2020 | 45%↑ |
| 2021 | 127%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2009 | $8.1M | - | - | - |
| 2015 | - | - | $647,000 | $410,000 |
| 2016 | $234,000 | $253,000 | $44,000 | $85,000 |
| 2018 | $809,000 | $1.6M | $3.5M | $4.2M |
| 2019 | $4.4M | $5.7M | $5.7M | $7.3M |
| 2020 | $7.6M | $5.8M | $9.1M | $11.0M |
| 2021 | $34.1M | $16.1M | $13.3M | $12.2M |
| 2022 | $10.4M | $10.5M | - | - |
Do you work at La Jolla Pharmaceutical?
Did La Jolla Pharmaceutical meet its revenue projections?
| Company Type | Public |
| Employees Number | 169 |
| Date Founded | 1989 |
| Headquarters | San Diego, California |
| Number of Locations | 1 |
| Revenue | $75.7M |
| Net Income | $19,660,000 |
| Gross Proft | $62.2M (2021) |
| Tax Rate | 0.0% |
| Total Assets | $101,230,000 |
| Ticker | LJPC |
La Jolla Pharmaceutical received early financing of $5.2M on 2011-04-18.
| Series | Round size | Date |
|---|---|---|
| Series Unknown | $5.2M | 04/2011 |
| Series Unknown | $17.8M | 10/2013 |
| Post Ipo Equity | $56.6M | 07/2014 |
| Post Ipo Equity | $111.4M | 09/2015 |
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Kosan Biosciences | - | - | 75 | - |
| Genetics Institute | - | $7.5M | 500 | - |
| RXi Pharmaceuticals | - | $21,000 | 10 | - |
| SenesTech | - | $1.0M | 33 | - |
| Morphotek | - | $4.8M | 1 | - |
| Halozyme | - | $1.0B | 136 | - |
| XBiotech | - | $4.0M | 56 | - |
| XOMA | - | $28.5M | 11 | - |
| CytoSorbents | - | $35.6M | 160 | - |
| Invitro | - | $710,000 | 25 | - |
Zippia gives an in-depth look into the details of La Jolla Pharmaceutical, including salaries, political affiliations, employee data, and more, in order to inform job seekers about La Jolla Pharmaceutical. The employee data is based on information from people who have self-reported their past or current employments at La Jolla Pharmaceutical. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by La Jolla Pharmaceutical. The data presented on this page does not represent the view of La Jolla Pharmaceutical and its employees or that of Zippia.
La Jolla Pharmaceutical may also be known as or be related to LA JOLLA PHARMACEUTICAL CO, La Jolla Pharmaceutical, La Jolla Pharmaceutical Co. and La Jolla Pharmaceutical Company.